Industry Urges Europe To Apply Lessons From COVID-19

Association Lays Out Proposals For Better Access To Medicines

In the wake of the COVID-19 pandemic, off-patent industry association Medicines for Europe has encouraged the EU to implement a pharmaceutical strategy that will address the root causes of medicines shortages and ensure sustainable healthcare policies going ahead, as well as optimizing European manufacturing and promoting innovation.

GPS
Medicines for Europe has offered suggestions on the European Union’s pharmaceutical roadmap • Source: Shtterstock

Acknowledging that the COVID-19 outbreak has demonstrated “the resilience of the European generic medicines industry which was able to massively scale up supply to address demand surges,” off-patent industry association Medicines for Europe has suggested that Europe should now “apply the lessons from COVID-19” as it pursues its pharmaceutical strategy roadmap.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Generics Bulletin for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Generics

More from Products